Chronic immune thrombocytopenic purpura in children: A survey of the canadian experience

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 2, 2007, Pages 95-100

  Belletrutti, Mark ^a,b,h   Ali, Kaiser ^a,b   Barnard, Dorothy ^a,c   Blanchette, Victor ^a,d   Chan, Anthony ^a,e   David, Michele ^a,g   Luke, Brian ^a,f   Price, Victoria ^a,c   Ritchie, Bruce ^a,h   Wu, John ^a,i  

^a Canadian Pediatric Chronic ITP Working Group   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic thrombocytopenia; Immunemediated; Pediatric

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RITUXIMAB; VINCRISTINE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CANADA; CANCER CENTER; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENECTOMY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AGE OF ONSET; CANADA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DATA COLLECTION; FEMALE; HUMANS; INFANT; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEX FACTORS; SPLENECTOMY;

EID: 33846807471     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3180320b36     Document Type: Article

References (32)

1. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999;105:871-875.
2. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol. 1992;29:72-82.
3. Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr. 1993;123:989-995.
4. Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994;344:703-707.
5. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
6. Kühne T, Imbach P, Bolton-Maggs PHB, et al., for the Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358:2122-2125.
7. Buchanan GR. Bleeding signs in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25:S42-S46.
8. Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25:S47-S51.
9. Gadner H. Management of immune thrombocytopenic purpura in children. Rev Clin Exp Hematol. 2000;5:201-221.
10. Kühne T, Elinder G, Blanchette VS, et al. Current management issues of child and adult immune thrombocytopenic purpura (ITP). Acta Paediatr. 1998;424:75-81.
11. Kühne T. Investigation and management of newly diagnosed childhood idiopathic thrombocytopenic purpura: problems and proposed solutions. J Pediatr Hematol Oncol. 2003;25:S24-S27.
12. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr. 2002;141:253-258.
13. Kühne T, Buchanan GR, Zimmerman S, et al., for the Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr. 2003;143:605-608.
14. Rosthøj S, Hedlund-Treutiger I, Zeller B, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr. 2003;143:302-307.
15. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr. 1998;133:334-339.
16. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child. 1994;71:251-253.
17. Vesely SK, Buchanan GR, Adix L, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology Oncology, 2001. J Pediatr Hematol Oncol. 2003;25:130-133.
18. Bolton-Maggs PHB, Dickerhoff R, Vora AJ. The nontreatment of childhood ITP (or "The art of medicine consists of amusing the patient until nature cures the disease"). Semin Thromb Hemost. 2001;27:269-275.
19. Bolton-Maggs PHB, Moon I. National audit of the management of childhood idiopathic thrombocytopenic purpura against UK guidelines: closing the loop: education and re-audit demonstrate a change in practice. Blood. 2001;98:58b.
20. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr. 2000;137:629-632.
21. Barnard D, Woloski M, Feeny D, et al. Development of diseasespecific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol. 2003;25:56-62.
22. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child. 1992;67:1056-1058.
23. Working Party of the British Committee for Standards in Haematology. General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-596.
24. Ben Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Hematol. 1994;91:1-6.
25. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2000;22:148-153.
26. Law C, Marcaccio M, Tam P, et al. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med. 1997;336:1494-1498.
27. Bussel JB, Kaufmann CP, Ware RE, et al. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol. 2001;67:27-33.
28. Fabris F, Cordiano I, Girolami A. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med. 1997;337:1088-1089.
29. Kondo H, Imamura T. High-dose intravenous immune globulin and the response to splenectomy monitoring with platelet-associated IgG in patients with idiopathic thrombocytopenic purpura. Eur J Haematol. 1998;61:213-215.
30. Ruivard M, Caulier MT, Vantelon JM, et al. The response to high-dose intravenous immune globulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol. 1999;105:1130-1132.
31. Holt D, Brown J, Terrill K, et al. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics. 2003;111:87-90.
32. Hemmila MR, Foley DS, Castle VP, et al. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin. J Pediatr Surg. 2000;35:967-972.